The authors note that due to a printer's error, on page 4460, Fig.  2 appears incorrectly in part. The middle and bottom panels were transposed. The corrected figure and its legend appear below.
MGAS5005
∆ccpA comp∆ccpA CcpA influences streptolysin S and hyalouronic acid capsule expression. (A) Colony phenotype of strain MGAS5005, its ⌬ccpA mutant derivative strain, and comp⌬ccpA strain on sheep blood agar plates. The ⌬ccpA strain has significantly increased hemolysis and decreased colony size compared with strain MGAS5005 and strain comp⌬ccpA. All three images are of same magnification with size indications at right. (B) Changes in colony hemolysis and size were associated with altered pel/sagA and hasA gene transcript levels. Strain MGAS5005 and ⌬ccpA were grown in THY to early-and late-logarithmic growth phase, and pel/sagA and hasA transcript levels were measured by real-time TaqMan QRT-PCR with the ⌬⌬C T method. Values above the x axis indicate higher gene transcript levels in the ⌬ccpA strain, whereas values below the x axis indicate higher gene transcript levels in strain MGAS5005. Error bars indicate standard deviation among quadruplicate samples done on two separate occasions.
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Fig. 2. Lack of functional GABAB receptors in orexin neurons of oxGKO mice.
Representative traces that show the effects of GABA (0.6 mM), muscimol (30 M) , and baclofen (100 M) in orexin neurons in control mice (A) and oxGKO mice (B) during current clamp recording. Drugs were applied during the periods indicated by bars.
Selective loss of GABA B receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture
Hypothalamic neurons that contain the neuropeptide orexin (hypocretin) play important roles in the regulation of sleep/wake. Here we analyze the in vivo and in vitro phenotype of mice lacking the GABAB1 gene specifically in orexin neurons (oxGKO mice) and demonstrate that GABAB receptors on orexin neurons are essential in stabilizing and consolidating sleep/wake states. In oxGKO brain slices, we show that the absence of GABAB receptors decreases the sensitivity of orexin neurons to both excitatory and inhibitory inputs because of augmented GABAA-mediated inhibition that increases the membrane conductance and shunts postsynaptic currents in these neurons. This increase in GABAA-mediated inhibitory tone is apparently the result of an orexin receptor type 1-mediated activation of local GABAergic interneurons that project back onto orexin neurons. oxGKO mice exhibit severe fragmentation of sleep/wake states during both the light and dark periods, without showing an abnormality in total sleep time or signs of cataplexy. Thus, GABAB receptors on orexin neurons are crucial in the appropriate control of the orexinergic tone through sleep/wake states, thereby stabilizing the state switching mechanisms.
hypocretin ͉ interneuron ͉ sleep stability ͉ synaptic input O rexin A and orexin B, also known as hypocretin-1 and hypocretin-2, are critical regulators of sleep/wake states (1). Orexin-producing neurons (orexin neurons) are localized exclusively in the lateral hypothalamic area (LHA) and send excitatory projections to the waking-active monoaminergic neurons in the hypothalamus and brainstem regions (1) . The importance of orexins in the maintenance of consolidated sleep/wake states is demonstrated by the fact that the sleep disorder narcolepsy is caused by orexin deficiency in human and animals (2) (3) (4) (5) . Recent investigations have suggested additional functions for orexins in the coordination of emotions, energy homeostasis, reward systems, drug addiction, and arousal (1) .
The regulatory mechanisms of orexin neurons are important for understanding the physiological basis of sleep/wake control. In vitro studies showed that the activity of orexin neurons is influenced by several neuropeptides and neurotransmitters (1) . Recent studies showed that orexin neurons receive innervations from several brain regions, including the limbic system, preoptic area, and monoaminergic neurons (1, 6) . Orexin neurons also receive glutamatergic and GABAergic innervations from local interneurons (1, 7) . In vitro electrophysiological studies showed that both GABA A and GABA B agonists inhibit the activity of orexin neurons (7) (8) (9) , but the physiological relevance of such regulation in vivo is unknown.
GABA B receptors (GABA B Rs) are heterodimers composed of GABA B1 and GABA B2 subunits, both of which are required for normal receptor function (10, 11) . GABA B receptors are coupled to G proteins and modulate synaptic transmission by activating postsynaptic G protein-gated inwardly rectifying K ϩ channels (GIRK channels, Kir3) and by controlling neurotransmitter release (12, 13) . Dysfunction of GABA B -mediated synaptic transmission in the central nervous system is proposed to occur in several neurological disorders (13) (14) (15) . The partial GABA B R agonist gammahydroxybutyrate (GHB) (16) is used to treat both the excessive sleepiness and cataplexy symptoms of human narcolepsy. GAB-A B R activation inhibits presynaptic release of both glutamate and GABA onto orexin neurons (9) and both pre-and postsynaptic GABA B Rs modulate the activity of orexin neurons (9) . In the present study, we engineered mice with a selective deletion of the GABA B1 gene specifically from orexin neurons (oxGKO mice) to study the consequences of the absence of GABA B Rs on orexin neuron function at the cellular and behavioral levels.
Results

Mice Selectively Lacking Functional GABAB Receptors in Orexin Neurons.
The GABA B1 subunit is essential for the assembly of functional GABA B receptors and mice lacking the GABA B1 subunit show a complete absence of GABA B responses (17) . To obtain mice with a deletion of the GABA B1 subunit gene restricted to orexinproducing neurons, orexin-Cre transgenic mice (SI Materials and Methods and Fig. S1 ) were mated with homozygous floxed GABA B1 mice possessing exons 7 and 8 of the GABA B1 allele flanked by lox-P sites (18) . Double immunofluorescence studies in wild-type control mice showed that many neurons in the LHA had GABA B1 -immunoreactivity (ir) in their soma and dendrites (Fig. 1 ). Among these, the majority of orexin-ir cells (orexin neurons) were positive for GABA B1 -ir (Fig. 1) . In contrast, neurons positive for both GABA B1 -ir and orexin-ir were rarely detectable in the brain of oxGKO mice, although there were many GABA B1 -ir-positive neurons in the LHA that were negative for orexin (Fig. 1) . We found that Ͻ8% of orexin neurons in oxGKO mice were double labeled for orexin and GABA B1 -ir. This may be the result of incomplete penetrance of Cre expression in orexin-Cre transgenic mice and/or incomplete deletion of lox-P sites in oxGKO mice. These observations indicate that in oxGKO mice, Ͼ90% of orexin neurons lack expression of GABA B receptors. Gross anatomical and histological studies failed to detect any structural abnormalities in the brain of oxGKO mice. Specifically, the number of orexin neurons in the LHA remained normal; the number of immunoreactive cells (located from 0.76 mm to 2.52 mm posterior to bregma) were 3420 Ϯ 124 and 3560 Ϯ 108 for control littermates and oxGKO mice, respectively (n ϭ 5). oxGKO mice showed normal development and normal hypothalamic neuropeptide expression levels (see SI Results).
Elimination of GABAB Receptors on Orexin Neurons Results in an
Increase of Local GABAergic Tone. The electrophysiological properties of orexin neurons were examined in oxGKO mice by patchclamp recordings using brain slice preparations (Fig. 2) . Application of GABA (0.6 mM) or the GABA A agonist muscimol (30 M) produced hyperpolarization of orexin neurons in both control (GABA B1 ?/ϩ , orexin-Cre Tg or GABA B1 flox/flox , orexin-Cre negative) and oxGKO mice ( Fig. 2 A and B) . GABA B agonist baclofen (100 M) hyperpolarized all orexin neurons tested in control slices (n ϭ 6) (Fig. 2 A) . As expected from the histological data in Fig. 1 , baclofen failed to induce hyperpolarization in 10 out of 12 orexin neurons tested in slices from six oxGKO mice (Fig. 2B) .
Orexin neurons lacking GABA B receptors showed a resting membrane potential and firing frequency similar to that of orexin neurons in control littermates (oxGKO: Ϫ55.0 Ϯ 2.9 mV, 5.1 Ϯ 2.6 Hz, n ϭ 12; control: Ϫ59.2 Ϯ 5.8 mV, 4.0 Ϯ 0.7 Hz, n ϭ 12). However, the frequency of fast spontaneous inhibitory postsynaptic currents (sIPSCs) of orexin neurons in oxGKO slices was significantly increased compared to that in slices from control littermates (oxGKO: 2.65 Ϯ 0.32 Hz, n ϭ 9; control: 1.59 Ϯ 0.12 Hz, n ϭ 13; P ϭ 0.011) (Fig. 3A) . Baclofen (100 M) decreased the frequency of sIPSCs to 3.4% and 23% of control values (in the absence of baclofen) in control littermates and oxGKO mice, respectively (Fig.  3A) . This suggests that sIPSCs on orexin neurons are elicited by GABA release from GABAergic terminals having presynaptic GABA B receptors. Next, we examined the effects of the GABA A and GABA B receptor antagonists, bicuculline (BIC) and CGP54626, respectively, on the activity of orexin neurons. Consistent with our previous study (9) , orexin neurons in wild-type control slices did not respond to application of the antagonists BIC (25 M) (Fig. 3B ) or CGP54626 (12 M) (data not shown). In contrast, orexin neurons in slices from oxGKO mice responded with depolarization to BIC application (n ϭ 4) (Fig. 3B ). These findings indicate that GABA A receptors are tonically activated in orexin neurons of oxGKO mice but not in wild-type mice. The spontaneous excitatory postsynaptic currents (sEPSCs) of orexin neurons from oxGKO and control littermate mice were comparable (oxGKO: 5.1 Ϯ 0.73 Hz, n ϭ 4; control: 5.8 Ϯ 1.2 Hz, n ϭ 3; P ϭ 0.74). These results indicate that the inhibitory GABA A input to orexin neurons is increased, while excitatory glutamatergic input to orexin neurons remains unchanged in oxGKO mice. This mechanism might prevent offset of the resting membrane potential and firing frequency of orexin neurons in oxGKO mice.
To further analyze the mechanisms that increase sIPSC frequency in orexin neurons lacking GABA B receptors, we recorded miniature IPSCs (mIPSCs) in the presence of tetrodotoxin (1 M). We found that the mean frequency and peak currents of mIPSCs in orexin neurons of oxGKO mice were comparable to that of control mice (oxGKO: 1.1 Ϯ 0.29 Hz, 94.5 Ϯ 21.0 pA, n ϭ 5; control: 0.99 Ϯ 0.26 Hz, 104.5 Ϯ 11.2 pA, n ϭ 6; P Ͼ 0.05 by Student's t test). These results suggest that the increase of sIPSCs in GABA B1 -deleted orexin neurons is the result of an increase in the local GABAergic tone, rather than an increase in GABA A receptors or the number of GABAergic synapses. Because of increase in GABA A input, the membrane resistance of orexin neurons in oxGKO mice was significantly decreased (control: 466 Ϯ 29 M⍀, n ϭ 25; oxGKO: 364 Ϯ 27 M⍀, n ϭ 12; P ϭ 0.017, Student's t test) (Fig. 3C) . Because the genetic deletion of the GABA B1 gene is restricted to orexin neurons (Fig. 1) , the increase in sIPSC frequency in orexin neurons must be attributable to a dysregulation of these neurons. Interestingly, we found that application of orexin A (1 M) increased the frequency of sIPSCs in wild-type orexin neurons (baseline: 1.6 Ϯ 0.25 Hz; orexin A: 2.7 Ϯ 0.33 Hz; washout: 1.5 Ϯ 0.32 Hz; n ϭ 5; P Ͻ 0.05 by one-way ANOVA), suggesting that orexin-induced activation of local GABAergic neurons is involved in the increase of inhibitory input to orexin neurons in oxGKO mice. We hypothesized that the activity of local GABAergic neurons expressing the orexin receptor is increased in oxGKO mice because of increased orexin release onto these interneurons. To evaluate this possibility, the orexin receptor antagonist SB334867 was used to block the orexin receptor-1 (OX 1 R). Preincubation with SB334867 (5 M) reduced the frequency of sIPSCs in orexin neurons of oxGKO mice (basal: 2.7 Ϯ 0.43 Hz, n ϭ 6; SB334867: 1.1 Ϯ 0.30 Hz, n ϭ 7; P ϭ 0.012 by Student's t test), but had no effect in control littermate mice (1.1 Ϯ 0.36 Hz, n ϭ 4 vs. 1.0 Ϯ 0.13 Hz, n ϭ 9, P ϭ 0.769 by Student's t test) (Fig. 3D) . These results indicate that orexin activates local GABAergic neurons via the OX 1 R resulting in an increase of the GABAergic synaptic input onto orexin neurons and that activity of these local circuits is increased in oxGKO mice. As illustrated in Fig. 3E , deletion of GABA B receptors from orexin neurons increases release of orexin onto local GABAergic interneurons that express OX 1 R. Increased GABAergic input from these interneurons results in increased membrane conductance of orexin neurons.
Orexin Neurons Lacking GABAB Receptors Show Decreased Responsiveness to Both Excitatory and Inhibitory Inputs. Although the basal membrane potential and firing frequency of orexin neurons in oxGKO mice were comparable to that of wild-type mice because of the compensatory increase in GABA A input, the absence of GABA B receptors caused abnormalities in these cells. We found that the effect of the GABA A agonist muscimol on orexin neuron activity was markedly attenuated in oxGKO mice ( Fig. 4A and B) . In current clamp mode, the threshold for hyperpolarization of orexin neurons by muscimol was 1.2 M and 6 M in littermate control slices and oxGKO slices, respectively. Thus, under basal conditions, GABA A receptors in these neurons are tonically activated by GABA, consistent with the results illustrated in Fig. 3B . The excitatory neurotransmitter, glutamate, was also less potent in inducing depolarizing currents in orexin neurons of oxGKO mice as compared with wild-type mice (Fig. 4 C and D) . Moreover, we found that effects of other inhibitory or excitatory neurotransmitters, 5-hydroxytryptamine (5-HT) (19) or cholecystokinin (CCK) (20) were also decreased (Fig. 4 E and F) . These findings suggest a decrease in the membrane resistance of orexin neurons in oxGKO mice (Fig. 3C) because of excess GABA A R activation by increased local GABAergic neuron activity, which results in decreased sensitivity to both excitatory and inhibitory inputs. In other words, the increase in membrane conductance (Fig. 3C ) may cause shunting of input stimuli, although the resting membrane potential was comparable to control.
oxGKO Mice Exhibit Severe Fragmentation of Sleep/Wake States. To examine the in vivo consequences of the decreased responsiveness of orexin neurons to both inhibitory and excitatory inputs, behavioral state patterns of oxGKO mice and control littermate mice were studied by simultaneous EEG/EMG recordings (5, 21, 22) . Typical hypnograms of oxGKO mice and control littermates during the 24-h dark and light periods are shown in Fig. 5A and B. Although the overall amounts of wakefulness, non-rapid eye movement (non-REM), and REM sleep were similar to controls ( and Table S1 ), oxGKO mice displayed severe fragmentation of sleep/wake states indicated by decreased awake, non-REM, and REM sleep episode durations and reduced REM latency ( Fig. 5D and Table S1 ). The power spectral profiling of EEG showed that delta power of oxGKO mice was significantly increased during non-REM sleep, and theta power was decreased during REM sleep (Fig. 5E ). These short bouts of sleep stages in oxGKO mice were accompanied by many more transitions than wild-type mice between all states except for the transition from REM to non-REM sleep stage (Fig. 5F ). The fragmentation of sleep/wake states in oxGKO mice was more severe than that previously described in orexin-knockout mice or orexin/ataxin-3 transgenic mice (5, 22) . However, neither the direct transitions from an awake state to REM sleep nor the cataplexy-like behavioral arrests were observed in oxGKO mice (Fig. 5F ). Interestingly, in contrast to the findings in orexin-deficient mice in which fragmentation is only observed during the dark period (5, 22) , fragmentation of behavioral states in oxGKO mice occurred during both the light and the dark periods ( Fig. 5 and Table S1 ).
Discussion
Orexin neurons are indispensable components of the regulatory mechanism that controls sleep/wake states. We have previously studied the regulatory mechanisms of orexin neurons in vitro (7, 8, 19, (23) (24) (25) . However, the physiological relevance of the regulatory mechanisms or inputs affecting the activity of orexin neurons remains unknown. In this study, we addressed the importance of GABA, the major inhibitory neurotransmitter in the mammalian central nervous system that has been strongly implicated in the regulation of sleep. GABA A receptor activation is well known to induce sleep-promoting responses (26) . Administration of the GABA B agonist baclofen (25 mg) before sleep in a clinical study also significantly prolonged total sleep time and reduced the time spent awake after sleep onset (27) . On the other hand, the GABA B antagonist CGP35348 increased the duration of both non-REM and REM sleep in aged rats compared to those in saline-injected controls when injected during the night (28) and decreased non-REM sleep while increasing the duration of waking and REM sleep when injected during the day (29) . These results suggest a complex role for GABA B receptors in the regulation of sleep/wake states.
Typical GABA B responses are almost completely eliminated in orexin neurons from oxGKO mice (Fig. 2) . GABA B agonistinduced postsynaptic effects were also eliminated and the sensitivity of orexin neurons to both GABA A receptor agonists and glutamate was decreased in oxGKO mice (Fig. 4) . As shown in Fig. 3 , we also found that inhibitory synaptic inputs to orexin neurons were increased in oxGKO mice. However, mIPSC frequencies were comparable between oxGKO and control orexin neurons. These observations suggest that the number of inhibitory synapses onto orexin neurons was not increased, but that activity-dependent inhibitory signals from local GABAergic neurons onto orexin neurons were increased in slice preparations from oxGKO mice. It will be intriguing to determine in future studies whether the GABAergic interneurons that provide input to orexin neurons also show a state-dependent firing pattern.
Because deletion of the GABA B R was restricted to orexin neurons (Fig. 1) , the increase in GABAergic influence must be attributable to the abnormality of the orexin neurons. We suggest that orexin neurons innervate local GABAergic neurons that, in turn, send inhibitory projections onto the orexin neurons. Presumably, in the oxGKO mice, orexin release onto local GABAergic interneurons is increased because of the lack of functional GABA B receptors in the nerve terminal or somatodendritic compartment of orexin neurons, leading to excessive activation of local GABAergic neurons (Fig. 3E) . Consistent with this hypothesis, preincubation of oxGKO slices with the OX 1 R antagonist reduced the sIPSC frequency to a level similar to that found in control slices (Fig. 3D) . Nevertheless, these alterations in synaptic input to the orexin neurons result in severe sleep/wake fragmentation in oxGKO mice during both the light and dark periods (Fig. 5 and Table S1 ), indicating that the GABA B receptor in orexin neurons is indispensable for proper regulation of sleep/wake states.
Recent studies have shown that orexin neurons are electrically quiescent during non-REM sleep bouts, whereas they are highly active during wake bouts (30) (31) (32) . During sleep, orexin neurons would be inhibited by GABAergic influences from neurons in the preoptic area (1), which are likely important for stably silencing orexin neurons (33, 34) . In oxGKO mice, both GABA A -and GABA B -mediated inhibition of orexin neurons was severely impaired (Figs. 2-4) . On the other hand, during wakefulness, orexin neurons would be activated by various excitatory inputs (1). In oxGKO mice, the effect of glutamate on orexin neurons was also severely impaired (Fig. 4) . Furthermore, we found that orexin neurons in oxGKO mice showed decreased responsiveness to 5-HT and CCK (Fig. 4) , known inhibitory and excitatory factors on orexin neurons. Therefore, orexin neurons in these mice are unlikely to be appropriately and tightly regulated by these inputs; consequently, oxGKO mice could not maintain stable wakefulness (Fig. 6 ). Our electrophysiological study showed that a minority (Ϸ17%) of the orexin neurons from oxGKO mice retained GABA B responses; the behavioral phenotype of these mice might be more severe if all orexin neurons lacked the response. A recent study showed that waking-active orexin neurons are codistributed with nonorexin waking-active neurons in the LHA, which may use glutamate as a neurotransmitter (32) . Activation of local GABAergic neurons in oxGKO mice may also result in decreased excitability of these nonorexin waking-active neurons, and further modulate the phenotype.
Orexin-deficient mice show behavioral instability and sleep/wake fragmentation only during the dark (active) period (5, 22) . In contrast, transgenic mice with constitutive overexpression of orexin show a fragmented sleep/wake phenotype only during the light (rest) period (35) . The activity of orexin neurons is high during the dark period (36) ; therefore, abnormality of orexin-deficient mice during this period might be expected. On the other hand, because the activity of orexin neurons is low or quiescent during the light period, the sleep/wake abnormality of orexin-overexpressing mice becomes apparent during this period (35) . However, oxGKO mice showed severe fragmentation of sleep/wake behavior during both the dark and light periods. The scenario in the previous paragraph also explains why these mice are affected both in the dark and light phases.
In oxGKO mice, we did not observe the cataplexy-like behavioral arrests or the direct transitions from wakefulness to REM sleep that are frequently seen in orexin-deficient animals. This result is consistent with the observation that mice overexpressing orexin do not show cataplexy, although these mice show fragmentation of sleep/wake states during the light period (35) . Together, these results suggest that fine tuning of orexinergic tone may not be necessary for inhibition of cataplexy and direct transition from wakefulness to REM sleep. On the other hand, tight regulation of orexin neurons is crucial for stability of sleep/wake states and maintenance of normal sleep/wake architecture (Fig. 5D) . Although total sleep time of oxGKO mice was comparable to that of control mice (Fig. 5C) , the highly fragmented sleep/wake architecture and short sleep bouts likely influence the sleep quality. Indeed, we observed differences in EEG power density distribution during both non-REM and REM sleep (Fig. 5E ). Delta power of oxGKO mice was increased during non-REM sleep, and theta power of these mice was decreased during REM sleep. These changes might result from a compensatory increase of sleep pressure in these mice because of poor sleep quality. Increased delta power indicates that oxGKO mice rapidly fall into deep sleep, further suggesting disrupted sleep architecture.
This study demonstrates the importance of GABA B activity within a defined neuronal circuit, in particular, that expression of these GABA B receptors in orexin neurons is necessary for appropriate maintenance of wakefulness and sleep state consolidation. The phenotype of oxGKO mice is characterized by impaired ability to maintain any behavioral state, which is one of the primary symptoms of human narcolepsy. Therefore, oxGKO mice may be a useful model in which to study narcolepsy without cataplexy. Because the partial GABA B agonist GHB is used clinically to extend both sleep bouts and subsequent wakefulness, thereby allowing narcoleptic humans to engage in longer periods of purposeful activity during their waking hours, oxGKO mice may also be a useful model in which to study the therapeutic action of GHB. This study suggests a specific mechanism by which GABA B agonists act on sleep physiology: these agonists may activate postsynaptic GABA B receptors on orexin neurons, which results in decreased GABA A input from the local GABAergic neurons (Fig. 3E) . This, in turn, may increase sensitivity of orexin neurons to inhibitory GABA A input from, for example, sleep-active neurons in the preoptic area. Because impaired ability to maintain wakefulness and consolidate sleep is also one of the hallmarks of sleep in the elderly, the results of the present study may be related to the neurobiological basis of the sleep fragmentation that occurs in aging. It will thus be interesting to determine whether there is an age-related impairment in GABAergic control of orexin neurons.
Materials and Methods
The methods are described in detail in SI Materials and Methods published on the PNAS Web site. oxGKO mice (BALB/cA: C57BL/6: DBA1 mixed background) were produced by mating GABAB1 flox/flox with GABAB1 flox/ϩ ; orexin-Cre mice. The genetic background of the mice used in this study was a mixture of BALB/c, C57BL/6, and DBA1 (75%: 21.875%: 3.125%). We found that wild-type mice, orexin-Cre Tg mice, GABA B1 flox/ϩ , orexin-Cre Tg mice and GABAB1 flox/flox (orexin-Cre-negative) mice all show the same phenotype regarding sleep/wake states (data not shown). In this study, orexin-Cre Tg mice were used as controls unless otherwise stated. For EEG/EMG recording, male oxGKO mice (n ϭ 10) and their weight-matched male control littermates [GABA B1 flox/ϩ , orexin-Cre Tg mice, n ϭ 5; or GABAB1 flox/flox (orexin-Cre-negative) mice, n ϭ 6] were implanted with electrodes at 12 weeks of age to record simultaneous EEG/EMG (5). EEG/EMG records were scored into 20-s epochs of each state. Brain slice preparations from oxGKO; orexin/eGFP mice subjected to patch-clamp recordings and electrophysiological analyses were as previously described (9, 21) . Fig. 6 . Proposed model in oxGKO mice displaying sleep/wakefulness fragmentation. GABA A input is increased by compensatory mechanisms, resulting in increased membrane conductance of orexin neurons in oxGKO mice. Therefore, orexin neurons in oxGKO mice show decreased responses to both excitatory and inhibitory input. In vivo, responses of orexin neurons in oxGKO mice to wakeactive excitatory input or sleep-active inhibitory input are inappropriate, resulting in severe instability of sleep/wake states. During the sleep period, orexin neurons in wild-type mice are strongly inhibited by GABAergic influence from the sleep-active neurons in the POA but orexin neurons in oxGKO mice cannot be effectively inhibited by GABA. On the other hand, during the waking period, orexin neurons would be activated by various excitatory inputs. In oxGKO mice, the effect of glutamate on orexin neurons was also severely impaired. Therefore, the activity of orexin neurons is not appropriately regulated to maintain wakefulness according to various inputs.
